Cognition Studio, Inc.

Design and Evolution of Synthetic Nucleocapsids 

Prev Next
Previous

Mini-Protein Binder Designs Against the Flu Virus

medical illustration of Scientists at the UW Institute for Protein Design (IPD) are pioneering the first synthetic nucleocapsids capable of packaging their genetic material and evolving specific properties. To support their publication and media efforts, Cognition created this editorial science visualization to highlight their elegant synthetic biology system that utilizes computational design and evolves based on exposure to complex environments (such as RNase A, blood, and murine circulation).
Next medical animation of Using mRNA as a drug, Moderna developed a personalized cancer vaccine (PCV) technology that could rapidly create one medicine for one patient. Cognition created an animation of Moderna’s PCV manufacture and MOA. By including voiceovers from Moderna subject matter experts and crafting a bright, friendly aesthetic, the animation is approachable but does not shy away from explaining the science. Visit https://cognitionstudio.com/expertise/moderna/ to see the case study.

Moderna's Personalized Cancer Vaccine (PCV)

Scientists at the UW Institute for Protein Design (IPD) are pioneering the first synthetic nucleocapsids capable of packaging their genetic material and evolving specific properties. To support their publication and media efforts, Cognition created this editorial science visualization to highlight their elegant synthetic biology system that utilizes computational design and evolves based on exposure to complex environments (such as RNase A, blood, and murine circulation).

Keywords: Color, 3D, Advertising / Marketing, Editorial, Technology, Biology, Biotechnology, Genetics, Molecular Biology, Virology

Cognition Studio, Inc.